E-mail a Wiley Online Library Link

A. Theodoridis, A. Konstantinidou, E. Makrantonaki and C.C. Zouboulis Malignant and benign forms of atrophic papulosis (Köhlmeier–Degos disease): systemic involvement determines the prognosis British Journal of Dermatology 170

Version of Record online: 13 JAN 2014 | DOI: 10.1111/bjd.12642

What's already known about this topic?

  • Existing information on atrophic papulosis comes mostly from case reports, and there has been no prospective study of the disease.

What does this study add?

  • The first data on the demographics, epidemiology and prognosis of atrophic papulosis are provided through a prospective cohort study.
  • The previously so-called ‘malignant atrophic papulosis’ (MAP) should be renamed ‘atrophic papulosis’ and classified into a malignant, systemic form (MAP) with severe prognosis and a more common, benign, cutaneous form (benign atrophic papulosis, BAP).
  • The probability of a benign course increases with the duration of BAP, and reaches 97% at 7 years.

Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf

Required = Required Field